Why US Fertility Clinic and IVF Laboratory Directors Should Run a Technology Discovery Sprint Before Committing to Custom Clinic Software

This article is part of our series on Custom Fertility and IVF Clinic Software Development for US Reproductive Medicine Practices: Building a Cycle Protocol, Witness and Cryostorage Chain-of-Custody System

Introduction: Two Audits Worth Running This Month

Two audits must be done for any engagement in this situation, regardless of whether or not any software gets developed. They matter before any custom software development begins.

The consent audit: select a random sample of the stored materials that are contained in the archive, dating back from last year, five years ago, or as far as storage goes, and attempt to produce the disposition consent for each one. Time this effort, document the deficiencies, and identify the version in force. Capturing those versioned consents later is a web application development job.

The custody audit: randomly sample some register entries and confirm them by physical comparison to the tank itself.

What Established Practices Usually Find

Established practices often find surprises in both cases. The recent records tend to hold up fine. The older ones are often partial. And the register has often drifted, with no one realizing until they checked.

Both discoveries have nothing to do with a software choice, and both describe an obligation the practice is already carrying, regardless of whether it lacks some feature or not. This article covers what else a discovery sprint should establish before any financial decision gets made. For reproductive medicine platform development, custom software development benefits from this audit happening first, and web application development for the patient portal is one of the areas a sprint should test against real requirements before anything gets built.

What a Discovery Sprint Actually Is

A discovery sprint typically takes four to six weeks, longer than in other sectors, since the audit process genuinely takes time to conclude, and it culminates in documented findings along with a costed recommendation rather than a proposal to develop something. It gets contracted separately from development, so the recommendation can honestly be that the practice should adopt a purpose-built platform instead.

The participants should include the practice director, the medical director, the laboratory director, the nurse leader who oversees the monitoring process, the person in charge of storage administration and patient contact, and the financial counselors.

The least recognized participant here is the storage administrator, but this is the very person who knows where consent documentation actually breaks down, since they are the one searching when things become difficult. The engagement should include observation of the morning review and time in the laboratory, with laboratory observation conducted in a way that never interferes with witnessing or work in progress. The output belongs to the practice and should be usable by anyone, including a platform vendor.

What the Sprint Should Establish

The Consent Position

The consent audit extended across the entire storage population: number of specimens, what consents exist for each, how readily accessible, which versions apply, and where review cycles have lapsed. This is the largest carried obligation in most established practices, and it is quantifiable within a few weeks of focused effort.

The Custody Chain

Register accuracy verified physically against the tanks, completeness of movement records checked, and witnessing consistency confirmed across the population. A gap here should be addressed without further delay, independent of any future software decision.

The Witnessing Position

The system currently in use, how it is integrated today, the reliability of the patient identity association, and the laboratory’s manual practices running alongside it, all assessed in a way that ensures laboratory work is never disrupted.

The Morning Review, Observed

How the monitoring decision round actually runs, where the time goes, and what the clinician is reaching for that is not currently in front of them. This produces the highest-value screen in the platform, and it genuinely cannot be designed from a description alone.

The Platform Test

Real requirements taken to the purpose-built fertility platforms directly, with regulatory content maintenance and witnessing integration treated as requirements rather than as minor details to check off later.

What the Practice Receives

A consent position report with population quantified, gaps identified by era, retrieval times measured, and remediation and migration effort costed as its own workstream. A custody chain assessment with register accuracy verified and any drift identified for correction. A witnessing integration assessment covering current position and what a platform change would actually require.

An observed monitoring workflow report with morning review requirements that follow directly from it. A compliance scope covering the partner and donor distinction as currently determined and recorded, laboratory qualification records, reporting completeness, and the state law questions the practice’s programs raise, with anything urgent flagged for counsel right away.

A platform test result classifying each requirement as achievable on a purpose-built platform, achievable elsewhere, or genuinely not possible anywhere yet. A defined first release with exclusions written down if building proceeds. And a costed comparison of at least three paths: implementing a purpose-built platform, building a narrow layer beside retained clinical and custody records, and fuller custom development, with long-term retention and retrieval testing shown as ongoing lines in each.

The Findings Worth Acting On Immediately

Three findings usually justify the engagement before any software decision gets made, and all three concern obligations rather than features.

Consent gaps, because a practice that cannot produce an executed consent for stored material carries an exposure that grows with every year of storage, and remediation, contacting patients and re-executing where appropriate, with counsel involved, can begin immediately. Register drift, because a position record that does not match the tank is a safety matter rather than a data quality one, and correcting it requires going through the tanks rather than fixing a database entry. And lapsed review cycles, where patients have not been contacted on the schedule the practice intended, with material sitting untouched while nobody confirms the original directions still reflect what people actually want.

None of these is a software problem. All three are reasons a practice should genuinely be glad it looked closely. A sprint that produces nothing actionable before the build begins was not really a sprint.

Reading the Recommendation

Implement a purpose-built platform when the test shows one covers the work. For most practices, this ends up being the finding, and two arguments carry real weight: regulatory content maintained by people who do it across many practices, and witnessing integrations that already exist and are proven in the field.

Build a narrow layer when the platform handles clinical, laboratory, and custody records adequately, and the actual gap is the patient experience or the analytics layer. Retaining the platform keeps the custody-critical parts with a system built and validated specifically for them, which is exactly where that responsibility belongs.

Build fully when network scale or unusual program combinations genuinely require it, which applies to a small number of organizations in practice. One consideration holds regardless of path: the consent remediation and register correction happen either way. Neither depends on the software decision, both carry real obligation, and starting them early is sensible even while the larger decision stays open.

Red Flags in the Conversation

Discovery offered free and contingent on winning the build. A fixed price quoted before the consent population has even been examined. Consent described as simple document storage. Long-term retention and retrieval testing missing from running costs entirely. No proposal to observe a morning review. No test run against the purpose-built platforms already in the market.

And the ones that should end the conversation immediately: any proposal to build a witnessing system rather than integrate with one; any feature described as making witnessing faster or more efficient; any automated disposition or discard workflow; any suggestion that software could grade or select embryos as a determination; any automated delivery of outcome results to patients; and stored material described in inventory or stock terms anywhere in the conversation.

The strongest positive signal, honestly, is a partner who asks how the practice handles a patient it cannot reach.

Final Thoughts

Directors who run the consent and custody audits before deciding anything learn what obligation the practice is actually carrying, which is the finding that matters most and does not depend on any software decision at all. And the right recommendation for most practices is a purpose-built platform, because the regulatory content and witnessing integrations represent permanent specialist work, and this is not a field where owning that alone makes sense.

If you are weighing custom fertility software, pulling a handful of stored specimens across two decades and timing how long it takes to produce each executed consent is the afternoon worth spending first. Learn more about digital transformation solutions from one of the leading AI software companies in the United States.

FAQ